Company Description
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally.
It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies.
In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles.
Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels.
Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets.
Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets.
Integer Holdings Corporation was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016.
The company was founded in 1970 and is headquartered in Plano, Texas.
| Country | United States |
| Founded | 1970 |
| IPO Date | Sep 29, 2000 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 10,500 |
| CEO | Joseph Dziedzic |
Contact Details
Address: 5830 Granite Parkway, Suite 1150 Plano, Texas 75024 United States | |
| Phone | 214-618-5243 |
| Website | integer.net |
Stock Details
| Ticker Symbol | ITGR |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001114483 |
| CUSIP Number | 45826H109 |
| ISIN Number | US45826H1095 |
| Employer ID | 16-1531026 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Joseph W. Dziedzic | President, Chief Executive Officer and Director |
| Diron Smith | Executive Vice President and Chief Financial Officer |
| McAlister C. Marshall II | Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Corporate Secretary |
| Payman Khales | President of Cardio and Vascular |
| John Harris | Executive Vice President of Global Operations and Manufacturing Strategy |
| Tom P. Thomas | Vice President, Corporate Controller and Principal Accounting Officer |
| Andrew Senn | Senior Vice President of Strategy, Business Development and Investor Relations |
| Margaret Carthy | Executive Vice President of Global Quality and Regulatory Affairs |
| Jim Stephens | President of Cardiac Rhythm Management and Neuromodulation |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 24, 2024 | 10-Q | Quarterly Report |
| Oct 24, 2024 | 8-K | Current Report |
| Oct 2, 2024 | 8-K | Current Report |
| Jul 31, 2024 | 144 | Filing |
| Jul 31, 2024 | 144 | Filing |
| Jul 30, 2024 | 144 | Filing |
| Jul 25, 2024 | 10-Q | Quarterly Report |
| Jul 25, 2024 | 8-K | Current Report |
| Jul 8, 2024 | 8-K | Current Report |
| Jul 1, 2024 | 8-K | Current Report |